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West Nile Virus (WNV) is a re-emerging pathogen and a
well-known agent of fatal encephalitis in several species,
including mouse and man; however immunopathogenic
mechanisms are poorly understood. We found that WNV
induced upregulation of the chemokine receptor/HIV
coreceptor CCR5 and its ligand CCL5 in mouse brain, as
well as influx of effector leukocytes, including CD4+ and
CD8+ T cells, NK cells, and macrophages, of which ~25%
expressed CCR5. Infection of CCR5-/- mice was rapidly
and uniformly fatal, whereas the majority of CCR5+/+
mice survived. Consistent with this, CCR5 32 homozy-
gotes were overrepresented in three of three cohorts of
symptomatic WNV seropositive individuals compared to
control populations. And were more likely to have a fatal
outcome. CCR5 appears to mediate resistance to fatal
WNV infection in mouse and man by coordinating leuko-
cyte recruitment to the infected brain. Thus CCR5 32
homozygosity is a strong genetic risk factor for sympto-
matic WNV infection in man. The results suggest that ther-
apeutic blockade of CCR5 may carry increased risk of
symptomatic and possibly fatal outcome should individ-
uals become infected with WNV.
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